Arulananda, S., & John, T. (2020). Adjuvant TKI therapy in resected EGFR-mutant non-small-cell lung cancer—ready for prime time? Transl Lung Cancer Res.
Chicago Style CitationArulananda, Surein, i Thomas John. "Adjuvant TKI Therapy in Resected EGFR-mutant Non-small-cell Lung Cancer—ready for Prime Time?" Transl Lung Cancer Res 2020.
Cita MLAArulananda, Surein, i Thomas John. "Adjuvant TKI Therapy in Resected EGFR-mutant Non-small-cell Lung Cancer—ready for Prime Time?" Transl Lung Cancer Res 2020.
Atenció: Aquestes cites poden no estar 100% correctes.